Finding 1236750 (2023-011)

Material Weakness Repeat Finding
Requirement
I
Questioned Costs
-
Year
2023
Accepted
2026-09-25
Audit: 412274
Auditor: CBIZ CPAS PC

AI Summary

  • Core Issue: UHU failed to consistently perform required suspension and debarment checks on vendors, risking federal funds being paid to ineligible parties.
  • Impacted Requirements: Lack of documentation and tracking of expenditures by federal award hindered compliance with Uniform Guidance, preventing effective testing of vendor eligibility.
  • Recommended Follow-Up: Establish formal policies and controls for screening vendors, ensure documentation is retained, and improve tracking of expenditures to support compliance and audit activities.

Finding Text

CRITERIA Under the Uniform Guidance, non-federal entities are prohibited from contracting with or making payments to parties that are suspended or debarred from participating in federal programs. Entities must verify vendor eligibility by performing the required suspension and debarment checks prior to entering into contracts or making payments under federal awards. CONDITION AND CONTEXT UHU did not consistently perform suspension and debarment screening procedures for vendors, suppliers, contractors, subrecipients, employees, and other parties paid with federal funds. During the fiscal year, payments were made without evidence that the required screening procedures were performed prior to disbursement. Although management indicated that screening was performed on an occasional basis, it was not applied consistently across all applicable transactions, and documentation to support such procedures was not retained. In addition, due to the lack of adequate tracking of expenditures by federal award and vendor within the accounting records, management was unable to provide a complete and reliable population of transactions subject to suspension and debarment requirements. As a result, sufficient information was not available to support the identification of applicable vendors and payments for testing purposes. CAUSE These deficiencies were due to the absence of policies, procedures, and controls to ensure that suspension and debarment screening is consistently performed, documented, and retained for all applicable parties prior to payment. In addition, UHU did not maintain an accounting structure capable of tracking expenditures by federal award and vendor, which limited management’s ability to identify the population of transactions subject to suspension and debarment requirements. EFFECT OR POTENTIAL EFFECT Failure to screen potential and current vendors, suppliers, contractors, subrecipients, employees, and other applicable parties increases the risk that federal funds may be inadvertently provided to individuals or entities that are suspended or debarred from participation in federal programs. In addition, due to the lack of adequate tracking of expenses by federal award, we were unable to obtain a complete and reliable population of vendors and transactions subject to suspension and debarment requirements. As a result, testing could not be effectively performed, and samples could not be selected to determine compliance with these requirements. This significantly limits the ability to verify compliance with the Uniform Guidance and increases the risk of undetected noncompliance, potential questioned costs, and regulatory consequences. RECOMMENDATION We recommend that UHU establish and implement formal policies, procedures, and internal controls to ensure that suspension and debarment checks are consistently performed for all applicable parties prior to entering into contracts or making payments using federal funds. These procedures should require that verification is performed through appropriate sources, documented, and retained as part of the organization’s records. Management should also strengthen controls over the tracking of expenditures by federal award and vendor within the accounting system to ensure that all transactions subject to federal compliance requirements can be readily identified. This will enable management to perform monitoring activities, support audit testing, and demonstrate compliance with the Uniform Guidance. Periodic reviews should be conducted to ensure that suspension and debarment procedures are being consistently applied and properly documented.

Corrective Action Plan

o Verify vendor and contractor eligibility through SAM.gov prior to contract award. o Perform periodic reviews of vendor eligibility throughout the contract period. o Maintain documentation of suspension and debarment checks within procurement files. o Incorporate suspension and debarment verification into procurement approval procedures. o Provide staff training regarding federal procurement requirements.

Categories

Procurement, Suspension & Debarment Subrecipient Monitoring Eligibility

Other Findings in this Audit

  • 1236723 2023-009
    Material Weakness Repeat
  • 1236724 2023-009
    Material Weakness Repeat
  • 1236725 2023-009
    Material Weakness Repeat
  • 1236726 2023-009
    Material Weakness Repeat
  • 1236727 2023-009
    Material Weakness Repeat
  • 1236728 2023-009
    Material Weakness Repeat
  • 1236729 2023-009
    Material Weakness Repeat
  • 1236730 2023-009
    Material Weakness Repeat
  • 1236731 2023-009
    Material Weakness Repeat
  • 1236732 2023-009
    Material Weakness Repeat
  • 1236733 2023-010
    Material Weakness Repeat
  • 1236734 2023-010
    Material Weakness Repeat
  • 1236735 2023-010
    Material Weakness Repeat
  • 1236736 2023-010
    Material Weakness Repeat
  • 1236737 2023-010
    Material Weakness Repeat
  • 1236738 2023-010
    Material Weakness Repeat
  • 1236739 2023-010
    Material Weakness Repeat
  • 1236740 2023-010
    Material Weakness Repeat
  • 1236741 2023-010
    Material Weakness Repeat
  • 1236742 2023-011
    Material Weakness Repeat
  • 1236743 2023-011
    Material Weakness Repeat
  • 1236744 2023-011
    Material Weakness Repeat
  • 1236745 2023-011
    Material Weakness Repeat
  • 1236746 2023-011
    Material Weakness Repeat
  • 1236747 2023-011
    Material Weakness Repeat
  • 1236748 2023-011
    Material Weakness Repeat
  • 1236749 2023-011
    Material Weakness Repeat
  • 1236751 2023-012
    Material Weakness Repeat
  • 1236752 2023-012
    Material Weakness Repeat
  • 1236753 2023-012
    Material Weakness Repeat
  • 1236754 2023-012
    Material Weakness Repeat
  • 1236755 2023-012
    Material Weakness Repeat
  • 1236756 2023-012
    Material Weakness Repeat
  • 1236757 2023-012
    Material Weakness Repeat
  • 1236758 2023-012
    Material Weakness Repeat
  • 1236759 2023-012
    Material Weakness Repeat
  • 1236760 2023-013
    Material Weakness Repeat
  • 1236761 2023-013
    Material Weakness Repeat
  • 1236762 2023-013
    Material Weakness Repeat
  • 1236763 2023-013
    Material Weakness Repeat
  • 1236764 2023-013
    Material Weakness Repeat
  • 1236765 2023-013
    Material Weakness Repeat
  • 1236766 2023-013
    Material Weakness Repeat
  • 1236767 2023-013
    Material Weakness Repeat
  • 1236768 2023-013
    Material Weakness Repeat
  • 1236769 2023-013
    Material Weakness Repeat
  • 1236770 2023-014
    Material Weakness Repeat
  • 1236771 2023-014
    Material Weakness Repeat
  • 1236772 2023-014
    Material Weakness Repeat
  • 1236773 2023-014
    Material Weakness Repeat
  • 1236774 2023-014
    Material Weakness Repeat
  • 1236775 2023-014
    Material Weakness Repeat
  • 1236776 2023-014
    Material Weakness Repeat
  • 1236777 2023-014
    Material Weakness Repeat
  • 1236778 2023-014
    Material Weakness Repeat
  • 1236779 2023-014
    Material Weakness Repeat
  • 1236780 2023-015
    Material Weakness Repeat
  • 1236781 2023-016
    Material Weakness Repeat
  • 1236782 2023-016
    Material Weakness Repeat
  • 1236783 2023-016
    Material Weakness Repeat
  • 1236784 2023-016
    Material Weakness Repeat
  • 1236785 2023-016
    Material Weakness Repeat
  • 1236786 2023-016
    Material Weakness Repeat
  • 1236787 2023-016
    Material Weakness Repeat
  • 1236788 2023-016
    Material Weakness Repeat
  • 1236789 2023-016
    Material Weakness Repeat
  • 1236790 2023-016
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.914 HIV EMERGENCY RELIEF PROJECT GRANTS $827,117
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $547,532
93.279 DRUG USE AND ADDICTION RESEARCH PROGRAMS $400,743
93.788 OPIOID STR $275,534
93.136 INJURY PREVENTION AND CONTROL RESEARCH AND STATE AND COMMUNITY BASED PROGRAMS $257,074
93.917 HIV CARE FORMULA GRANTS $58,312
93.242 MENTAL HEALTH RESEARCH GRANTS $41,967
93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH $25,429
93.940 HIV PREVENTION AND SURVEILLANCE ACTIVITIES-HEALTH DEPARTMENT BASED $4,314